Today, Novartis CEO Vas Narasimhan announced the company’s financial results for the third quarter of 2018.
Oct 18, 2018

Commenting on the results, Vas Narasimhan, CEO of Novartis, said: “We progressed our breakthrough medicines pipeline including our leading advanced therapy platforms in cell and gene and continued our strong operational performance.”

Read the media release

Q3 2018 financial results Infographic

Q3 2018 Infographic

Executive Committee of Novartis (ECN) Biographies

ECN Biographies